17-alpha-Hydroxyprogesterone: Clinical Trials

5 trials of 17-alpha-Hydroxyprogesterone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow 17-alpha-Hydroxyprogesterone: new trials by email Literature Review of 17-alpha-Hydroxyprogesterone trials Research Report on 17-alpha-Hydroxyprogesterone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Pregnancy Outcomes With Progesterone
17P, Placebo - Pre-term Birth, HIV-1-infection
Phase 3CompletedUniversity of North Carolina, Chapel Hill8002018-02-072021-07-22
Progestagens for the Tertiary Prophylaxis of Preterm Delivery
17 alpha-hydroxy progesterone caproate, micronized Progesterone, Control - Preterm Delivery, Neonatal Complications
Phase 3CompletedUniversity of Modena and Reggio Emilia2542010-02-012016-09-23
Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
17-alpha Hydroxyprogesterone Caproate, Castor oil - Preterm Delivery
Phase 2CompletedAmerican University of Beirut Medical Center2902006-10-012013-07-19
Study of Pharmacology of 17-OHPC in Pregnancy
17-OHPC, Blood Draws - Pregnancy
Phase 2CompletedUniversity of Pittsburgh612006-03-012015-02-27
Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies
17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement, 17 alpha-hydroxy progesterone caproate and Placebo supplement - Preterm Birth
Phase 3CompletedThe George Washington University Biostatistics Center8002005-02-012019-07-12

Conditions studied

Premature Birth (4)

Sponsors

American University of Beirut Medical Center (1)  ·  The George Washington University Biostatistics Center (1)  ·  University of Modena and Reggio Emilia (1)  ·  University of North Carolina, Chapel Hill (1)  ·  University of Pittsburgh (1)

Countries

United States (2)  ·  Italy (1)  ·  Lebanon (1)  ·  Zambia (1)

Top investigators

Anwar H Nassar, MD (1)  ·  Elizabeth A Thom, PhD (1)  ·  Fabio Facchinetti, M.D. (1)  ·  Jeff Stringer, MD, FACOG (1)  ·  Margaret Harper, MD (1)  ·  Menachem Miodovnik, MD (1)  ·  Steve N. Caritis, MD (1)

Results publications

PMID 20093894, PMID 21173653, PMID 21508745, PMID 23635681, PMID 28594783, PMID 30813934, PMID 34509197

NIH funding

2009 (1), R01HD087119 (1), U10HD021410 (1), U10HD027860 (1), U10HD027869 (1), U10HD027915 (1), U10HD027917 (1), U10HD034136 (1), U10HD034208 (1), U10HD036801 (1), U10HD040485 (1), U10HD040500 (1), U10HD040512 (1), U10HD040544 (1), U10HD040545 (1)